Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL16612173 | 0.81 | GPR3 (0.32) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL8011536 | 0.81 | GPR3 (0.32) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL64813 | 0.80 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL2053629 | 0.76 | CA12 (0.31) | ALDH1A1 | |
| SCHEMBL1058967 | 0.75 | — | — | |
| SCHEMBL18779 | 0.75 | — | — | |
| Hydrogen Sulfide SCHEMBL15467095 | 0.72 | — | — | |
| SCHEMBL30271302 | 0.72 | — | — | |
| Iodide SCHEMBL2789427 | 0.72 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL31124997 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106317130-B | The batch synthesis method of table lactose | 中国农业大学 | 2019-02-05 | — | — | CN | claimed |
| US-20060166278-A1 | Method for synthesizing sugar chain(s) | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-07-27 | — | — | US | claimed |
| EP-1640379-A1 | METHOD OF SYNTHESIZING SUGAR CHAIN | Mitsubishi Chemical Corporation (JP) | 2006-03-29 | — | — | EP | claimed |
| CN-1293200-A | Process for preparing saponin library by one-step or two-step random reaction | SHANGHAI INST ORGANIC CHEM (CN) | 2001-05-02 | — | — | CN | claimed |
| CN-1293199-A | Saponin library of rhammose-substituted beta-o-gluco-diosgenin and its preparing process and application | SHANGHAI INST ORGANIC CHEM (CN) | 2001-05-02 | — | — | CN | claimed |
| US-11332490-B1 | Compounds and methods for treating osteoarthritis | ACADEMIA SINICA (TW) | 2022-05-17 | — | — | US | disclosed |
| CN-106317130-B | The batch synthesis method of table lactose | 中国农业大学 | 2019-02-05 | — | — | CN | disclosed |
| EP-2857411-B1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | ZHEJIANG HISUN PHARM CO LTD (CN) | 2017-12-06 | — | — | EP | disclosed |
| EP-2415775-B1 | AGENT FOR INHIBITING THICKENING OF PERITONEAL MEMBRANE | CCI CORP (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-9310366-B2 | Anthrax carbohydrates, synthesis and uses thereof | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-9250238-B2 | Pathogen detection | PURDUE RESEARCH FOUNDATION (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150284419-A1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2015-10-08 | — | — | US | disclosed |
| US-5908833-A | GLUCOCORTICOSTEROID CHEMICALLY BOUND TO A SUGAR | AKTIEBOLAGET ASTRA (SE) | 1999-06-01 | — | — | US | disclosed |
| EP-0912613-A1 | SYNTHETIC POLYSACCHARIDES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI (FR) | 1999-05-06 | — | — | EP | disclosed |
| US-5773596-A | Preparation of ganglioside having ceramide moiety labeled with fluorescence | DAIKIN INDUSTRIES, LTD. (JP) | 1998-06-30 | — | — | US | disclosed |
| WO-1998003554-A1 | SYNTHETIC POLYSACCHARIDES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SANOFI (FR) | 1998-01-29 | — | — | WO | disclosed |
| EP-0765883-A1 | GANGLIOSIDE HAVING FLUORESCENCE-LABELLED CERAMIDE PORTION AND PROCESS FOR PRODUCING THE SAME | DAIKIN INDUSTRIES, LIMITED (JP) | 1997-04-02 | — | — | EP | disclosed |
| CN-1114654-A | Novel colon- or ileum-specific steroid derivatives | ASTRA AB (SE) | 1996-01-10 | — | — | CN | disclosed |
| EP-0678097-A1 | NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES | AKTIEBOLAGET ASTRA (SE) | 1995-10-25 | — | — | EP | disclosed |
| WO-1994015947-A1 | NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES | ASTRA AKTIEBOLAG (SE) | 1994-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284419-A1 | METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF | HABP2, HPSE, PLG | ALDH1A1 2108/4885L3MBTL1 3461/4885 |
| US-11332490-B1 | Compounds and methods for treating osteoarthritis | SULT1E1, STS, ARSA | ALDH1A1 288/4885L3MBTL1 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.